UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 217

Sortiert nach

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

The Lancet (British edition), 2011-12, Vol.378 (9809), p.2104-2111

2011

Volltextzugriff (PDF)

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

The New England journal of medicine, 2017-03, Vol.376 (11), p.1027-1037

2017

Volltextzugriff (PDF)

Using natural language processing to extract clinically useful information from Chinese electronic medical records

International journal of medical informatics (Shannon, Ireland), 2019-04, Vol.124, p.6-12

2019

Volltextzugriff (PDF)

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-10, Vol.36 (30), p.2995-3006

2018

Volltextzugriff (PDF)

Metastatic Timing and Genetic Heterogeneity in the Evolution of a Pancreatic Neuroendocrine Tumor

The American journal of gastroenterology, 2021-04, Vol.116 (4), p.844-845

2021

Volltextzugriff (PDF)

Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1151-1156

2015

Volltextzugriff (PDF)

DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma

Oncogene, 2020-04, Vol.39 (16), p.3229-3244

2020

Volltextzugriff (PDF)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3320-3326

2013

Volltextzugriff (PDF)

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

The New England journal of medicine, 2012-09, Vol.367 (10), p.895-903

2012

Volltextzugriff (PDF)

An ontology-based classification of Ebstein's anomaly and its implications in clinical adverse outcomes

International journal of cardiology, 2020-10, Vol.316, p.79-86

2020

Volltextzugriff (PDF)

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3552-3559

2008

Volltextzugriff (PDF)

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

The New England journal of medicine, 2012-09, Vol.367 (10), p.895-903

2012

Volltextzugriff (PDF)

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2007-05, Vol.25 (15), p.1960-1966

2007

Volltextzugriff (PDF)

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-10, Vol.28 (29), p.4417-4424

2010

Volltextzugriff (PDF)

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

Journal of neuro-oncology, 2020-08, Vol.149 (1), p.65-71

2020

Volltextzugriff (PDF)

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4268-4275

2008

Volltextzugriff (PDF)

Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial

The lancet oncology, 2015-11, Vol.16 (15), p.1463-1472

2015

Volltextzugriff (PDF)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Journal of clinical oncology, 2010-01, Vol.28 (1), p.29-34

2010

Volltextzugriff (PDF)

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2350-2357

2008

Volltextzugriff (PDF)

Comparison of error correction algorithms for Ion Torrent PGM data: application to hepatitis B virus

Scientific reports, 2017-08, Vol.7 (1), p.8106-11, Article 8106

2017

Volltextzugriff (PDF)

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

The New England journal of medicine, 2005-07, Vol.353 (2), p.133-144

2005

Volltextzugriff (PDF)

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

The New England journal of medicine, 2005-06, Vol.352 (25), p.2589-2597

2005

Volltextzugriff (PDF)

Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5240-5247

2007

Volltextzugriff (PDF)

Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials

Journal of clinical oncology, 2008-01, Vol.26 (1), p.54-59

2008

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Englisch
(217)
Japanisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(127)
Humans
(118)
Male
(72)
Female
(68)
Oncology
(67)
Middle Aged
(54)
Aged
(51)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(34)
Lung Neoplasms - Drug Therapy
(34)
Adult
(32)
Tumors
(32)
Quality Of Life
(26)
Aged, 80 And Over
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Lung Neoplasms - Mortality
(21)
Carcinoma, Non-Small-Cell Lung - Mortality
(20)
Genetics & Heredity
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

Using natural language processing to extract clinically useful information from Chinese electronic medical records

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer

Metastatic Timing and Genetic Heterogeneity in the Evolution of a Pancreatic Neuroendocrine Tumor

Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT

DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

An ontology-based classification of Ebstein's anomaly and its implications in clinical adverse outcomes

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

Comparison of error correction algorithms for Ion Torrent PGM data: application to hepatitis B virus

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer

Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials

Suchergebnisse filtern